The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Randomized Phase II Study of Neoadjuvant Combined-Modality Chemoradiation for Distal Rectal Cancer: Radiation Therapy Oncology Group Trial 0012
Abstract
Purpose: To evaluate the rate of pathologic complete response and toxicity of neoadjuvant chemoradiation for advanced T3/T4 distal rectal cancers in a randomized phase II study Patients and Methods: Patients with clinical T3/T4 distal rectal cancers were randomly assigned in a phase II study to receive combined neoadjuvant chemoradiotherapy followed by surgical resection. Patients were randomly assigned to receive continuous venous infusion (CVI) fluorouracil (FU) 225 mg/m 2 per day, 7 days per week, plus pelvic hyperfractionated radiation 55.2 to 60 Gy at 1.2 Gy bid (arm 1) or CVI FU 225 mg/m 2 per day Monday to Friday, 120 hours per week plus irinotecan 50 mg/m 2 once weekly for 4 weeks plus pelvic radiation therapy 50.4 to 54 Gy at 1.8 Gy per day (arm 2). Surgery was performed 4 to 10 weeks after completion of neoadjuvant therapy. The primary end point of this study was pathologic complete response (pCR). Secondary end points included acute and late normal tissue morbidity. Results: A total of 106 patients were entered onto the study, with 103 assessable for response. The overall resectability rate was 93%. The median time to surgery was 7 weeks. Tumor downstaging was observed in 78% of patients in both arms. The pCR rate for all assessable patients was 26% in each arm. For patients who had surgery, the pCR rate was also the same (28%) in both arms. Acute and late toxicity was also similar. Grade 3 and 4 acute hematologic and nonhematologic toxicity occurred in 13% and 38% in arm 1 and 12% and 45% in arm 2, respectively. Conclusion: Although the overall complete response rate and toxicity seems similar in both arms, this is the first multi-institutional study to establish a relatively high (28%) pCR rate after neoadjuvant therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer
Sauer, R., Becker, H., Hohenberger, W., Rödel, C., Wittekind, C., Fietkau, R., Martus, P., Tschmelitsch, J., Hager, E., Hess, C. F., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040694 · Cited by 6,050
Jemal, A., Tiwari, R. C., Murray, T., Ghafoor, A., Samuels, A., Ward, E., Feuer, E. J., & Thun, M. J. (2004) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.54.1.8 · Cited by 3,984
de Gramont, A., Figer, A., Seymour, M., Homerin, M., Hmissi, A., Cassidy, J., Boni, C., Cortes-Funes, H., Cervantes, A., Freyer, G., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.16.2938 · Cited by 3,815
Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer
Saltz, L. B., Cox, J. V., Blanke, C., Rosen, L. S., Fehrenbacher, L., Moore, M. J., Maroun, J. A., Ackland, S. P., Locker, P. K., Pirotta, N., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009283431302 · Cited by 3,005
Improved Survival with Preoperative Radiotherapy in Resectable Rectal Cancer
(1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361402 · Cited by 2,517
Effective Surgical Adjuvant Therapy for High-Risk Rectal Carcinoma
Krook, J. E., Moertel, C. G., Gunderson, L. L., Wieand, H. S., Collins, R. T., Beart, R. W., Kubista, T. P., Poon, M. A., Meyers, W. C., Mailliard, J. A., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103143241101 · Cited by 1,879
O'Connell, M. J., Martenson, J. A., Wieand, H. S., Krook, J. E., Macdonald, J. S., Haller, D. G., Mayer, R. J., Gunderson, L. L., & Rich, T. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408253310803 · Cited by 1,136
GÉRARD, A., BUYSE, M., NORDLINGER, B., LOYGUE, J., PÈNE, F., KEMPF, P., BOSSET, J.-F., GIGNOUX, M., ARNAUD, J.-P., DESAIVE, C., et al. (1988) · Annals of Surgery · doi:10.1097/00000658-198811000-00011 · Cited by 665
Survival after Postoperative Combination Treatment of Rectal Cancer
(1986) · New England Journal of Medicine · doi:10.1056/nejm198611133152014 · Cited by 529
Studies on fluorinated pyrimidines. II. Effects on transplanted tumors.
Heidelberger, C., Griesbach, L., Montag, B. J., Mooren, D., Cruz, O., Schnitzer, R., & Grunberg, E. (1958) · PubMed · Cited by 429
Valentini, V., Coco, C., Picciocchi, A., Morganti, A. G., Trodella, L., Ciabattoni, A., Cellini, F., Barbaro, B., Cogliandolo, S., Nuzzo, G., et al. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)02764-5 · Cited by 320
Goldberg, P. A., Nicholls, R. J., Porter, N. H., Love, S., & Grimsey, J. E. (1994) · European Journal of Cancer · doi:10.1016/0959-8049(94)00312-s · Cited by 269
Higgins, G. A., Humphrey, E. W., Dwight, R. W., Roswit, B., Lee, L. E., & Keehn, R. J. (1986) · Cancer · doi:10.1002/1097-0142(19860715)58:2<352::aid-cncr2820580226>3.0.co;2-d · Cited by 226
Gérard, J.-P., Chapet, O., Nemoz, C., Romestaing, P., Mornex, F., Coquard, R., Barbet, N., Atlan, D., Adeleine, P., & Freyer, G. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.10.045 · Cited by 206
Kaminsky-Forrett, M.-C., Conroy, T., Luporsi, E., Peiffert, D., Lapeyre, M., Boissel, P., Guillemin, F., & Bey, P. (1998) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(98)00345-9 · Cited by 201
Mohiuddin, M., Regine, W. F., John, W. J., Hagihara, P. F., McGrath, P. C., Kenady, D. E., & Marks, G. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(99)00486-1 · Cited by 185
Self-citationMohiuddin, M., Hayne, M., Regine, W. F., Hanna, N., Hagihara, P. F., McGrath, P., & Marks, G. M. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)00732-x · Cited by 170
Self-citationPreoperative radiochemotherapy in rectal cancer:
Bosset, J.-F., Magnin, V., Maingon, P., Mantion, G., Pélissier, É., Mercier, M., Chaillard, G., & Horiot, J.-C. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(99)00411-3 · Cited by 161
Crane, C. H., Skibber, J. M., Birnbaum, E. H., Feig, B. W., Singh, A. K., Delclos, M. E., Lin, E. H., Fleshman, J. W., Thames, H. D., Kodner, I. J., et al. (2003) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(03)00532-7 · Cited by 117
Chan, A., Wong, A. O., Langevin, J. M., Jenken, D. A., Heine, J. A., Buie, D. W., & Johnson, D. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)00692-1 · Cited by 91
Response to Preoperative Chemoradiation in Stage II and III Rectal Cancer
Brown, C. L., Ternent, C. A., Thorson, A. G., Christensen, M. A., Blatchford, G. J., Shashidharan, M., & Haynatzki, G. R. (2003) · Diseases of the Colon & Rectum · doi:10.1007/s10350-004-6714-y · Cited by 62
Roh, M. S., Colangelo, L. H., Wieand, S., O’Connell, M., Petrelli, N. J., Smith, R. E., Mamounas, E. P., Hyams, D. M., & Wolmark, N. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.22.90140.3505 · Cited by 58
Bosset, J.-F., Calais, G., Mineur, L., Maingon, P., Radošević-Jelić, L., Daban, A., Bardet, É., Beny, A., Collette, L., & Briffaux, A. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.22.90140.3504 · Cited by 31
Cited by
Maas, M., Nelemans, P. J., Valentini, V., Das, P., Rödel, C., Kuo, L.-J., Calvo, F. A., García-Aguilar, J., Glynne-Jones, R., Haustermans, K., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70172-8 · Cited by 1,945
Self-citationCunningham, D., Atkin, W., Lenz, H.-J., Lynch, H. T., Minsky, B., Nordlinger, B., & Starling, N. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60353-4 · Cited by 1,351
Aschele, C., Cionini, L., Lonardi, S., Pinto, C., Cordio, S., Rosati, G., Artale, S., Tagliagambe, A., Ambrosini, G., Rosetti, P., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.34.4911 · Cited by 763
Gérard, J.-P., Azria, D., Gourgou-Bourgade, S., Martel-Laffay, I., Hennequin, C., Etienne, P.-L., Vendrely, V., François, E., de La Roche, G., Bouché, O., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.8376 · Cited by 747
Martin, S. T., Heneghan, H. M., & Winter, D. C. (2012) · British Journal of Surgery · doi:10.1002/bjs.8702 · Cited by 637
Metadata
- Authors
- Mohiuddin, M., Winter, K., Mitchell, E., Hanna, N., Yuen, A., Nichols, C., Shane, R., Hayostek, C., & Willett, C.
- Venue
- Journal of Clinical Oncology
- Published
- 2006-02
- Volume
- 24
- Issue
- 4
- Pages
- 650-655
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2088327075
- Cited by
- 255
- References
- 24
- FWCI
- 11.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.